The average one-year price target for Protalix BioTherapeutics (NYSEAM:PLX) has been revised to $12.75 / share. This is a decrease of 10.71% from the prior estimate of $14.28 dated November 14, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback